# Genetic Polymorphisms in Ranibizumab Treatment in Wet Age-Related Macular Degeneration (AMD)

> **NCT01676506** · NA · UNKNOWN · sponsor: **Russian Academy of Medical Sciences** · enrollment: 300 (estimated)

## Conditions studied

- Age-Related Macular Degeneration

## Interventions

- **DRUG:** Ranibizumab
- **PROCEDURE:** Ranibizumab Injection

## Key facts

- **NCT ID:** NCT01676506
- **Lead sponsor:** Russian Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-10
- **Primary completion:** 2013-10
- **Final completion:** 2015-10
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2012-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01676506

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01676506, "Genetic Polymorphisms in Ranibizumab Treatment in Wet Age-Related Macular Degeneration (AMD)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01676506. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*